Loading stock…

Synopsys, Inc. (SNPS) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

SNPSSynopsys

Revenue FY25$7.1B

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+15%8

Revenue, next 1Y+38%9

Revenue, next 3Y, CAGR+21%9

Revenue, next 5Y, CAGR+17%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+89%10

EPS growth, FY27E+25%8

EPS growth, FY28E+21%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 15%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 21%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 15%/yr over the last 3 years and is set to grow 21%/yr from here.

The runway holds up: revenue is set to grow 17%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 25%/yr vs revenue 21%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG79 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+28%10

3-month return+16%9

YTD return+7%6

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+3%5

3-year return+6%3

5-year return+72%7

MOMENTUM ASSESSMENT

STRENGTHS

It's up 3% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+28%) and over three months (+16%).

WATCH

Average long-term results. Multi-year returns are middling (+6.2% over three years and +72% over five), roughly average for the market.

Returns sit at the market level so far this year (+7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Synopsys. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

SNPSSynopsys

Revenue FY25$7.1B

GROWTH RATING↗

VERY STRONG92 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+15%8

Revenue, next 1Y+38%9

Revenue, next 3Y, CAGR+21%9

Revenue, next 5Y, CAGR+17%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+89%10

EPS growth, FY27E+25%8

EPS growth, FY28E+21%8

GROWTH ASSESSMENT

STRENGTHS

It out-grows 92% of companies worldwide.

Revenue grew 15%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to grow 21%/yr over the next 3 years, ahead of most of the market.9/10

Revenue grew 15%/yr over the last 3 years and is set to grow 21%/yr from here.

The runway holds up: revenue is set to grow 17%/yr over five years.9/10

Earnings are set to grow in step with sales (EPS about 25%/yr vs revenue 21%/yr).

WATCH

None flagged.

WEAKNESSES

None flagged.

BOTTOM LINE

Hyper Compounder

A top-tier grower that's speeding up.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

STRONG79 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+28%10

3-month return+16%9

YTD return+7%6

MID & LONG-TERM▾SCORE

% of 52-week high93%9

1-year return+3%5

3-year return+6%3

5-year return+72%7

MOMENTUM ASSESSMENT

STRENGTHS

It's up 3% over the past year, now 7% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (+28%) and over three months (+16%).

WATCH

Average long-term results. Multi-year returns are middling (+6.2% over three years and +72% over five), roughly average for the market.

Returns sit at the market level so far this year (+7%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Synopsys. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Synopsys, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Synopsys. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Synopsys. Get the full investment case.

Premium